Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy
Abstract Despite significant clinical progress, checkpoint blockade remains limited by variable response rates, resistance, and toxicity. Activating costimulatory receptors offers a promising alternative to enhance anti-tumor immunity. However, there is insufficient understanding of how to mimic phy...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2025-12-01
|
| Colecção: | Nature Communications |
| Acesso em linha: | https://doi.org/10.1038/s41467-025-67882-3 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|